No black box warning on record for Dayvigo

As of the latest FDA labeling reviewed, Dayvigo (LEMBOREXANT) does not carry a black box warning. Standard warnings and precautions still apply — see the full Dayvigo medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS CNS Depressant Effects and Daytime Impairment: Impairs alertness and motor coordination including morning impairment. Risk increases with dose and use with other central nervous system (CNS) depressants. For patients taking DAYVIGO 10 mg, caution against next-day driving and other activities requiring complete mental alertness. ( 5.1 ) Sleep Paralysis, Hypnagogic/Hypnopo

No black box warning on record for Dayvigo

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS CNS Depressant Effects and Daytime Impairment: Impairs alertness and motor coordination including morning impairment. Risk increases with dose and use with other central nervous system (CNS) depressants. For patients taking DAYVIGO 10 mg, caution against next-day driving and other activities requiring complete mental alertness. ( 5.1 ) Sleep Paralysis, Hypnagogic/Hypnopo

Dayvigo Black Box Warning

No black box warning on record for Dayvigo

Other warnings & precautions

Dayvigo Black Box Warning

No black box warning on record for Dayvigo

Other warnings & precautions